MOLECULAR AND
CELLULAR BIOLOGY |
Unraveling the Myocardial
Interstitium in Heart Failure: Mechanisms and Prospects for
Therapy
Francis G. Spinale, Medical
University of South Carolina, Charleston, SC, U.S.A. |
Molecular Control of
Cardiac Metabolic Switches: Role of PPAR and Other Nuclear
Receptors
Daniel P. Kelly,
St. Louis, MO, U.S.A. |
Cellular, Ionic, Molecular
and Genetic Aspects of the Brugada Syndrome
Charles Antzelevitch,
Masonic Medical Research Laboratory, Utica, NY, U.S.A. |
The Cause of Dystrophin
Disruption, Translocation and Fragmentation in the Progression
of Heart Failure
Teruhiko Toyo-oka,
University of Tokyo, P/Graduate School of Med., Tokyo, Japan
|
Protein Kinase and the
Progression of Cardiac Disease
Peter M. Buttrick,
University of Illinois, Chicago, IL, U.S.A. |
Modulation of MMP
Expression by Cytokines and Beta Blocker
Matthias Pauschinger,
University Hospital Benjamin Franklin, Berlin, Germany |
Sarcoplasmic Reticulum
Function in Heart Failure Due to Volume Overload
Thomas Netticadan, St.
Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada |
Matrix Metalloproteinases
in Heart Failure: Potential for Treatment?
Anique Ducharme,
Institut de Cardiologie de Montreal, Montreal, Quebec, Canada |
VASCULAR BIOLOGY,
ENDOTHELIAL FUNCTION |
Chronic
Inhibition of Nitric Oxide Synthase Induces Hypertension and
Cardiomyocyte Mitochondrial Collagen Remodeling in the Absence
of Hypertrophy
Marcos A. Rossi,
University of Sao Paulo, Ribeirao Preto, S.P., Brazil |
Endothelial
Protection by Nitric Oxide and Aspirin: Role of Heme
Oxygenase-1 and Ferritin
Henning Schroeder,
Martin Luther University School of Pharmacy, Halle (Saale),
Germany |
GENETIC STUDIES |
Preventing Progressive Left
Ventricular Dilation Is Integral to Normalization of Gene
Expression in Heart Failure
Hani N. Sabbah,
Henry Ford Heart & Vascular Institute, Detroit, MI, U.S.A. |
Genetic Mechanisms of
Heart Failure
Jeffrey A. Towbin,
Texas Children's Hospital/Baylor College of Med, Houston, TX,
U.S.A. |
Chip-ping Away at Heart Failure
Choong-Chin Liew,
Brigham and Women's Hospital, Boston, MA, U.S.A. |
Genetic Alteration in
Natriuretic Peptide Receptor -A Causes Hypertension and
Congestive Heart Failure
Kailash Pandey,
Tulane University School of Medicine, New Orleans, LA, U.S.A. |
Synergistic Polymorphisms of
b1- and a2c-Adrenergic Receptors and the Risk of Congestive
Heart Failure
Lynne E. Wagoner,
University of Cincinnati, Cincinnati, OH, U.S.A. |
Differential
Gene Expression in the Failing and Rescued Heart
Burns C. Blaxall,
Duke University Medical Center, Durham, NC, U.S.A. |
CELL TRANSPLANTATION
|
Autology Bone Marrow: Results
of Clinical Study
Ron Waksman,
Washington Cardiology Center, Washington, DC, U.S.A. |
Cell Transplantation for
Cardiovascular Repair: A Moving Target
Doris Taylor,
Duke University Medical Center, Durham, NC, U.S.A. |
Myoblast Cell Transplantation
for the Treatment of Congestive Heart Failure
Nabil Dib,
Arizona Heart Institute and Hospital, Phoenix, AZ, U.S.A. |
Stem Cell Therapy for
Myocardial Regeneration: Do We Need Direct Intramyocardial
Injection?
Raj R. Makkar,
Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A. |
Real-time MRI for the delivery and surveillance of mesenchymal stem
cells after recent acute myocardial infarction in swine.
Robert J. Lederman, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
|
ANGIOGENESIS |
Angiogenesis Clinical Trials
Timothy A. Sanborn,
Evanston Northwestern Healthcare, Evanston, IL, U.S.A. |
Options for No-Option Patients:
Complex Interventions, Angiogenesis/Myogenesis
Roger Laham,
BIDMC / Harvard Medical School, Boston, MA, U.S.A. |
Evolving
Treatment Strategies for Unrevascularizable Ischemic Coronary
Disease
Greg Barsness,
Mayo Clinic, Rochester, MN, U.S.A. |
ECHOCARDIOGRAPHY |
Newer Aspects of
Echocardiography
Navin C. Nanda,
University of Alabama at Birmingham, Birmingham, AL, U.S.A. |
Echocardiography in 2003: New
Questions, New Challenges, New Answers
Fausto J. Pinto,
University Hospital Sta Maria, Lisbon Universit, Lisboa Codex,
Portugal |
Role of Miniaturized
Echocardiographic Platforms in Clinical Practice
Kirk T. Spencer,
University of Chicago Medical Center, Chicago, IL, U.S.A. |
New Trends in Postoperative
Diagnosis and Treatment Utilizing Substernal Epicardial
Echocardiography
Anthony P. Furnary,
Oregon Health Sciences University Hospital, Portland, OR,
U.S.A. |
Feasibility of Simultaneous
Echocardiographic Imaging of Myocardial Perfusion and Regional
Left Ventricular Function Using Color-Encoded Contrast Enhanced
Power Modulation
Jeanne M. DeCara,
University of Chicago Medical Center, Chicago, IL, U.S.A. |
NEW
DEVELOPMENTS IN CARDIAC IMAGING |
Complementary Roles of Cardiac
CT and Nuclear Cardiology in Assessment of the Cardiac Patient
Daniel S. Berman,
Cedars Sinai Medical Center, Los Angeles, CA, U.S.A. |
Diagnostic Role of MRI in
Congestive Heart Failure
Vinzenz Hombach,
Vice-President of the University of Ulm, Ulm, Germany |
Noninvasive Detection of
Coronary Vasomotor Dysfunction: An Index of Preclinical
Atherosclerosis
Heinrich R. Schelbert,
University of California, Los Angeles, Los Angeles, CA, U.S.A. |
Analysis of the Christmas
Trial: Is the Search For Hibernating Myocardium Important?
Avijit Lahiri,
Northwick Park Hospital & Instit. for Med. Res., Middlesex,
England |
Clinical Applications of
Coronary CT
Michael Motro,
Sheba Medical Center, Tel Hashomer, Israel |
Imaging in the
Management of the Patient with Heart Failure
Francesco Fedele, Universita' Degli Studi Di Roma "la Sapienza", Roma, Italy |
Application of
Angioscopy for Diagnosis of Atherosclerosis
Takanobu Tomaru,
Toho University Sakura Hospital, Japan |
The
Wavefront of Myocardial Contraction Revisited
Manel
Ballester,
Universitat de Lleida, Lieida, Spain |
Monitoring the
Effectiveness of Medical Therapy for Ischemic Heart Disease with
ECG-Gated SPECT Myocardial Perfusion Imaging
Ronald G.
Schwartz, University
of Rochester Medical Center, Rochester, NY, U.S.A. |
Assessment of
Myocardial Viability by Cardiac Magnetic Resonance
Luis J. Jimenez-Borreguero,
Hospital Universitario Principe Asturias, Madrid, Spain |
ATHEROSCLEROSIS: PATHOGENESIS AND
TREATMENT |
Vaccination for
Atherosclerosis Prevention: Promises and Problems
Prediman K. Shah,
Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A.
|
Pathogen Burden,
the Prime Culprit of Atherosclerosis
Junbo Ge,
Shanghai Medical University / Zhongshan Hospital, Shanghai, P.R.
China |
The Vulnerable
Plaque: New Insights into Old Morphology
Christian C.
Haudenschild, American
Red Cross, Rockville, MD, U.S.A. |
How Macrophages
Get Fat
Howard S. Kruth,
NHLBI, NIH, Bethesda, MD, U.S.A. |
Antioxidants and
Atherosclerosis
Jean-Claude
Tardif, Montreal Heart
Institute, Montreal, Quebec, Canada
|
Atherosclerosis Regression - A Myth or Reality?
Adarsh Kumar,
Govt. Medical College/G.N.D. Hospital, Amritsar, India |
EPIDEMIOLOGY OF
ISCHEMIC HEART
DISEASE |
Socio-Economic
Status and Its Clinical Implication on Coronary Artery Disease
Christos
Pitsavos, University
of Athens, Chalandri Athens, Greece |
Climatological
Variations and Coronary Heart Disease Mortality
Demosthenes B.
Panagiotakos,
University of Athens, Glyfada, Attica, Greece |
ACUTE CORONARY SYNDROMES, ACUTE MYOCARDIAL INFARCTION |
Silent
Infarction and Ischemia: Revisited in 2003
Shlomo Stern,
Bikur Cholim Hospital, Jerusalem, Israel |
Use of 80-Lead
Body Map Electrocardiography to Diagnose Acute ST Elevation
Myocardial Infarction
Joseph P. Ornato,
Virginia Commonwealth Health System, Richmond, VA, U.S.A. |
Role of P-Selectin
Antagonists in Acute Myocardial Infarction
Jean-Francois
Tanguay, Montreal
Heart Institute, Montreal, Quebec, Canada |
Acute Coronary
Syndromes: Diagnostic Challenges and Therapeutic Options
Osama Abdel-Aziz,
Cairo, Egypt |
ANTITHROMBOTIC AND
ANTIPLATELET THERAPY |
Antithrombotic Therapy for Patients with Heart Failure: Blocking
Platelets and Fibrin Formation
James H.
Chesebro,
Mayo Clinic Jacksonville, Jacksonville, FL, U.S.A. |
Reperfusion Injury Can Not Be Prevented Because It Does Not
Exist
William Ganz,
Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A. |
Modern
Developments in Thrombolytic Therapy in Acute Myocardial
Infarction
Hans Martin
Hoffmeister, Chefarzt
Prof. Dr. H.M. Hoffmeister, Solingen, Germany |
Development of
Novel Antithrombotics Agents
Paul R.
Eisenberg, Eli Lilly
and Company, Indianapolis, IN, U.S.A. |
Approach to
Patients of Acute Non-ST Elevation Myocardial Infarction with
Early Conservative Management
Shih-Chung Lin,
Vice President, Kuo General Hospital, Tainan, Taiwan |
Anticoagulation
During Pregnancy
Tasneem Naqvi,
Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A. |
INTERVENTIONAL
CARDIOLOGY |
Clinical Impact
of Periprocedural Microembolizations During PCI
Michael Haude,
University of Essen, Essen, Germany |
Catheter Closure
of Ventricular Septal Defects
Horst Sievert,
Cardiovascular Center Bethaniem CCB, Frankfurt, Germany |
Application of
Excimer Laser Angioplasty in Acute Coronary Syndromes
On Topaz,
McGuire VA Medical Ctr, Division of Cardiology, Richmond, VA,
U.S.A. |
Use of
Intracardiac Echocardiography for Closure of ASDs and PFOs
Saibal Kar,
Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A. |
Left Ventricular
Function After Angioplasty (PTCA or Stenting) of Infarct Related
Artery: Early and Midterm Results
David G.
Iosseliani, Moscow,
Russia |
STENTS: NEW DEVICES / OPTIMAL APPLICATION |
Stents, Design
and Vessel Wall Biology: Two Decades of Progress
Rafael Beyar,
Rambam Medical Center, Haifa, Israel |
Drug Eluting
Stents: Special Considerations in the Application of Restenosis
George W.
Vetrovec, Virginia
Commonwealth University, Richmond, VA, U.S.A. |
Results with
Drug Eluting Stents in the Real World
Volker Klauss,
Klinikum der Universitat Munchen, Munchen, Germany |
Current Status
of Drug Eluting Stents - Did Expectation Translate Into Reality?
A. H. Gershlick,
University of Leicester, Leicester, England, United Kingdom |
Nanotechnology -
Novel Technology Using Ultrapure Metals to Improve Endovascular
Stents
Steven R. Bailey,
University of Texas Health Sciences Center, San Antonio, TX,
U.S.A. |
Drug Eluting
Stents: One Year Later, Where Are We Now?
Maurice
Buchbinder, Sharp
Health Care, San Diego, CA, U.S.A. |
Is Carotid
Angioplasty and Stenting Under Protection Becoming the Gold
Standard Treatment of Carotid Artery Stenosis?
Michel Henry,
Nancy, France |
DRUG THERAPY IN
ISCHEMIC HEART DISEASE |
Beta Blockade as
Cardioprotection in Coronary Patients in the Era of Thrombolysis,
Percutaneous Coronary Intervention, and ACE Inhibition
Barry F. Uretsky,
University of Texas Medical Branch at Galveston, Galveston, TX,
U.S.A. |
Management of
Stable Angina: Drugs, Devices, Stents or Coronary Bypass Surgery
Udho Thadani,
University of Oklahoma HSC, Oklahoma City, OK, U.S.A. |
Reducing CV
Events - Focus on New Pharmacologic Trials
Robert DiBianco,
Washington Adventist Hospital, Takoma Park, MD, U.S.A. |
MODIFICATION
OF LIPOPROTEINS AND CORONARY DISEASE |
New
Understanding of Atherosclerosis: Is the Lipid Theory Debunked?
Carlos M.
Ferrario, Wake Forest
University School of Medicine, Winston-Salem, NC, U.S.A. |
Statins and
Stroke: The Mode of Action in Stroke Prevention and Therapy
Rodolfo Paoletti,
University of Milan, Milan, Italy |
Polyunsaturated
Fats in the Management of the Diseased Artery
W. Virgil Brown,
Atlanta VA Medical Center (111), Decatur, GA, U.S.A. |
Atherosclerosis
Regression by Lipid Lowering
Clive Rosendorff,
VA Medical Center, Bronx, NY, U.S.A. |
Effects of
Statins on Vascular Function and Myocardial Ischemia
Prakash C.
Deedwania, University
of California, San Francisco Program, Fresno, CA, U.S.A. |
Pleiotropic
Actions of Statin Agents Including Applicability to CHF
Scott Wright,
Mayo Clinic, Rochester, MN, U.S.A. |
HYPERTENSION |
Treating
Hypertension in Patients Who Present Coronary Artery Disease,
Heart Failure and/or Cardiac Arrhythmias
Ariel J. Reyes,
Institute of Cardiovascular Theory, Montevideo, Uruguay |
Angiotensin
and the Left Ventricle
Philip R.
Liebson,
Rush Presbyterian-St. Luke's Medical Center, Chicago, IL, U.S.A. |
Management of
Exercise Related Hypertension
Yzhar Charuzi,
Los Angeles, CA, U.S.A. |
New and Evolving
Strategies in the High Risk Hypertensive Patient
Gabriel B. Habib,
Houston VA Medical Center, Houston, TX, U.S.A. |
DIABETES AND HEART DISEASE |
Diabetes and
Coronary Valvular Disease
Jonathan Abrams,
University of New Mexico HSC, Albuquerque, NM, U.S.A. |
PRIMARY PREVENTION
OR CORONARY ARTERY DISEASE |
Guidelines for the Preventrion of
Coronary Heart Disease: What Does Reality Look Like? Findings
from Germany and Other European Countries
Ulrich Keil,
University of Munster, Munster, Germany |
What is an
Optimal Diet?
Dean Ornish,
Preventive Medicine Research Institute, Sausalito, CA, U.S.A. |
DILATED
CARDIOMYOPATHY: VARIOUS ETIOLOGIES |
Advances in the Diagnosis and Treatment of Inflamatory
Cardiomyopathy
Heinz-Peter
Schultheiss,
University Hospital Benjamin Franklin, Berlin, Germany |
Cytokines in
Adriamycin Induced Heart Failure
Pawan K. Singal,
University of Manitoba, Winnipeg, Manitoba, Canada |
Ventricular
Remodeling Post-Infarction and Collagen
Bodh I. Jugdutt,
University of Alberta Hospitals, Edmonton, Alberta, Canada |
Virus
Myocarditis as a Predictor of Dilated Cardiomyopathy,
Possibilities for the Prevention of DCM
Nodar N.
Kipshidze, Institute
of Experimental and Clinical Therapy, Tbilisi, Rep. of Georgia |
Myocardial
Flow-Metabolism Abnormalities in Dilated Cardiomyopathy: Cause
or Effect of Ventricular Dysfunction?
Danilo Neglia,
CNR Institute of Clinical Physiology, Pisa, Italy |
Arrhymogenic
Right Ventricular Dysplasia/Cardiomyopathy - Diagnosis and
Treatment
Charles Y. Lui,
University of Arizona Health Sciences Center, Tucson, AZ, U.S.A. |
Chagas' Disease:
What All Physicians Need to Know
Anis Rassi Jr.,
Goiania, Brazil |
NATRIURETIC
PEPTIDES, ENDOTHELIN IN HEART FAILURE |
The Appropriate
Use of BNP as a Diagnostic Tool in Heart Disease
Richard J. Rodeheffer,
Mayo Clinic, Rochester, MN, U.S.A. |
Systemic and Coronary Hemodynamic Effects of B-Type Natriuretic Peptide Nesiritide
Kanu Chatterjee, University Of California San Francisco, CA, U.S.A.
|
Differential
Secretion Patterns of Natriuretic Peptides in a Heart Failure
Population and Their Association with Cardiac Function
Denise M. Heublein,
Cardiorenal Research Laboratory, Mayo Clinic, Rochester, MN,
U.S.A. |
BNP in Acute
Heart Failure
Andrew Burger,
Beth Israel Deaconess Medical Center, Boston, MA, U.S.A. |
Endothelin
Antagonists in Cardiovascular Disease: New
Preclinical and Clinical Data
Rene R. Wenzel,
University Hospital Essen, Essen, Germany |
Natriuretic
Peptides in Asymptomatic and Symptomatic Severe Aortic Stenosis
Jutta Bergler-Klein,
University of Vienna, Vienna, Austria |
PREDICTORS AND
MARKERS OF HEART FAILURE OUTCOME |
Heart Rate
Variability in Systolic and Diastolic Heart Failure of the
Elderly
John S.
Gottdiener, St.
Francis Hospital, Roslyn, NY, U.S.A. |
Implantable
Physiologic Optimized Dosimeter/Synchonizer for Treating
Advanced Congestive Heart Failure
Neal Eigler,
Cedars-Sinai Medical Center, Los Angeles, CA 90048, U.S.A. |
LEFT VENTRICULAR
HYPERTROPHY AND HYPERTROPHIC CARDIOMYOPATHY |
Catheter Based
Treatment for HOCM: Studies on Myocardial Infarction in a Unique
Clinical Infarct Model
Horst Kuhn,
Bielefeld, Germany |
Non-sarcomeric
Causes of Familial Hypertrophic Cardiomyopathy
Lameh
Fananapazir, National
Heart, Lung and Blood Institute, Bethesda, MD, U.S.A. |
DIASTOLIC
DYSFUNCTION |
The Clinical
Characteristics, Co-morbid Conditions and Natural History of
Patients Hospitalized for Heart Failure with a Normal Left
Ventricular Ejection Fraction
Marc Klapholz,
Saint Vincent Catholic Medical Center, New York, NY, U.S.A. |
ROLE OF THE
PERICARDIUM |
Pericardial
Involvement in End-Stage Renal Disease
Martin A. Alpert,
St. John's Mercy Medical Center, St. Louis, MO, U.S.A. |
HEART FAILURE IN
WOMEN |
Psychosocial and Hormonal
Contributors to the Development and the Progression of Heart
Failure in Females
Vera Regitz-Zagrosek,
German Heart Institute, Berlin, Germany |
EXERCISE PHYSIOLOGY
IN HEART FAILURE |
Exercise
Training in Patients with Chronic Heart Failure: Why, When, and
How Much?
Gunter Gorge,
Klinikum Saarbruecken, Saarbrucken, Germany |
RENAL ASPECTS |
The Changing
Role of Ultrafiltration for Management of Decompensated Heart
Failure - Not Just for the Nephrologist Anymore
Mitchell
Saltzberg, Midwest
Heart Specialists, Downers Grove, IL, U.S.A. |
NEW HORIZONS IN THE MANAGEMENT OF HEART FAILURE |
BNP: New
Strategies for the Treatment of Cardiovascular Disease
John C. Burnett,
Mayo Clinic and Foundation, Rochester, MN, U.S.A. |
Hospitalization
for Heart Failure: Pathophysiology and Management
Mihai
Gheorghiade,
Northwestern University, Chicago, IL, U.S.A. |
Decompensated
Heart Failure - Vasodilators or Inotropes
Uri Elkayam,
USC School of Medicine, Los Angeles, CA, U.S.A. |
New Approaches
to the Treatment of Heart Failure
Robert C. Bourge,
The University of Alabama, Birmingham, Birmingham, AL, U.S.A. |
New Therapies
for Heart Failure
Robert E. Hobbs,
The Cleveland Clinic Foundation, Cleveland, OH, U.S.A. |
Is Palliative
Care Useful for Patients With Severe Heart Failure?
Herbert J.
Geschwind, University
of Paris XII, Val-de-Marne, Creteil, France |
The Management
of Heart Disease in 2003: Pearls and Pitfalls
Maryl R. Johnson,
University of Wisconsin-Madison, Madison, WI, U.S.A. |
Digoxin
Pharmacotherapy in Patients with Chronic Cor Pulmonale. In Fact,
Is It a Dilemma?
Nestor J.
Angomachalelis,
Aristotle University, School of Medicine, Thessaloniki,
Macedonia, Greece |
Targeting
Phospholamban as a Therapeutic Modality in Heart Failure
Litsa Kranias,
University of Cincinnati Medical Center, Cincinnati, OH, U.S.A. |
CARDIAC PACING
STRATEGIES IN HEART FAILURE |
Electrical
Therapy for Congestive Heart Failure
Masood Akhtar,
Sinai Samaritan Medical Center, Milwaukee, WI, U.S.A. |
Electrophysiological Interventions in Management of Cardiac
Failure
Gerard
Marcel Guiraudon,
University Hospital, London, Ontario, Canada |
Heart Failure and the Need for Device Therapy
William
Abraham,
The Ohio State University, Columbus, Ohio, U.S.A. |
CARDIOPULMONARY
RESUSCITATION |
Why Are the
Guidelines for Basic CPR Wrong?
Gordon A. Ewy,
University of Arizona Sarver Heart Center, Tucson, AZ, U.S.A. |
Novel Steps in
the Journey Toward Optimizing Care for the Victim of Sudden
Cardiac Arrest
Alessandro
Capucci, Ospedale
Civile, Piacenza, Italy |
Advances in Cardiopulmonary Resuscitation
Gerasimos S.
Filippatos,
Athens, Greece |
ARRHYTHMIAS I:
SUDDEN CARDIAC DEATH / RISK STRATIFICATION / IMPLANTABLE
ANTIARRHYTHMIC DEVICES |
Risk
Identification in Arrhythmic Athletes with Fatal or Resuscitated
Cardiac Arrest
Francesco
Furlanello,
Policlinico San Donato Milanese - Milan, Povo (TN), Italy |
Sudden Cardiac
Death Prevention in High Risk Familial Syndrome
Win-Kuang Shen,
Mayo Clinic, Rochester, MN, U.S.A. |
Do All Patients
With Coronary Artery Disease and an Ejection Fraction of Less
Than 30% Need a Defibrillator?
Douglas L.
Packer, St. Mary's
Hospital Complex, Rochester, MN, U.S.A. |
Sudden Cardiac
Death: The Clinical and Public Health Challenges
George Mensah,
Center for Disease Control and Prevention, Atlanta, GA, U.S.A. |
New Alternatives
for Patients Suffering In-Hospital Cardiac Arrest: the Role of
Fully Automatic Defibrillators
Antonio
Martinez-Rubio,
Hospital
of Sabadell,
Barcelona, Spain |
Post-infarction
Signaling Pathways as Targets for Novel Therapeutic
Interventions
Nabil E. El-Sherif,
SUNY Downstate Medical Center, Brooklyn, NY, U.S.A.
|
Primary
Prevention of Sudden Death: Current Role of Implantable Device
Therapy
David J. Wilber,
Loyola University Medical Center, Maywood, IL, U.S.A. |
Frontiers in
Complete Congenital Heart Block
Mohamed Boutjdir,
NY Harbor Healthcare System, Brooklyn, NY, U.S.A. |
ARRHYTHMIAS II:
DIAGNOSIS / DRUG THERAPY / ABLATION |
Interatrial
Block: Electromechanical Disease of the Left Atrium - A Very
Common Condition
David H. Spodick,
University of Massachusetts Medical School, Worcester, MA,
U.S.A. |
Atrial Flutter Mechanisms: New Concepts of
Interest for the Clinician
Jose L. Merino,
Hospital General Universitarion "La Paz", Madrid, Spain |
Recent Advances
in the Non-Pharmacologic Treatment of Atrial Fibrillation
Peter G. Guerra,
Montreal Heart Institute, Montreal, Quebec, Canada |
VALVULAR HEART
DISEASE / HEART VALVE SURGERY / DISEASES OF THE THORACIC AORTA |
Confirmation of
Contractility as a Prognostic Index in Aortic Regurgitation, and
the Cellular/Molecular Basis of the Deficit
Jeffrey S. Borer,
The New York Hospital, Cornell Medical Center, New York, NY,
U.S.A. |
Etiology of
Valvular Heart Disease in the 21st Century
Harisios
Boudoulas, Academy of Athens, Athens, Greece |
Transcatheter
Treatment of Mitral Regurgitation
Peter C. Block,
Emory University Hospital, Atlanta, GA, U.S.A. |
Mechanical
Properties of the Aorta in Normal and Aneurysmal States
John A.
Elefteriades, Yale
University School of Medicine, New Haven, CT, U.S.A. |
Mitral and Tricuspid Reconstruction in the
Patients with Heart Failure
Ninoslav
Radovanovic,
University Clinic of Cardiovascular Surgery, Sremska Kamenica,
Novi Sad, Yugoslavia |
Rational Behind
the Biological Aortic Valve Replacement
Borut Gersak,
University Medical Center, Ljubljana, Slovenia |
Robotic Mitral
Valve Repair: Improved Results and Patient Satisfaction
Mark S.
Slaughter, Christ
Hospital and Medical Center, Oak Lawn, IL, U.S.A. |
NEW APPROACHES TO
SURGICAL REVASCULARIZATION |
Totally
Endoscopic CABG
Daniel Loisance,
Hopital Henri Mondor, Cretail Cedex, France |
Purely Internal
Mammary Artery CABG for Complete Myocardial Revascularization
Patrick Nataf,
Center Cardiologique du Nord, saint Denis, France |
Facilitative
Techniques to Advance Minimally Invasive Concept of Coronary
Artery Bypass Surgery and Surgical Treatment for Heart Failure
Valavanur A.
Subramanian, Lenox
Hill Hospital, New York, NY U.S.A. |
Assessment of
Myocardial Viability in Heart Failure: Who Should Be
Revascularized?
Vasken Dilsizian,
University of Maryland School of Medicine, Baltimore, MD, U.S.A. |
Recent Advances in Cardiac Surgery
Mercedes K.
C. Dullum,
Washington Regional Cardiac Surgery PC, Washington DC, U.S.A. |
SURGERY FOR LV
DYSFUNCTION, CARDIAC TRANSPLANTATION,
MECHANICAL SUPPORT |
Fetal Intervention to Prevent
Hypoplastic Left Heart Syndrome
Steven Colan,
Children's Hospital Boston, Boston, MA, U.S.A. |
Heart Transplantation with
Bicaval and Pulmonary Venous Anastomoses
Lawrence S. Czer,
Cedars-Sinai Medical Center, Los Angeles, CA, U.S.A. |
Surgical Trials for the
Management of Heart Failure
Dan M. Meyer,
University of Texas Southwestern Medical Center, Dallas, TX,
U.S.A. |
Management of Pulmonary
Hypertension in Cardiac Transplant Recipients
Geetha Bhat,
University of Louisville and Jewish Hospital, Louisville, KY,
U.S.A. |
Mechanical Circulatory Support
in Infants and Children with Cardiac Disease
Brian W. Duncan,
The Children's Hospital at the Cleveland Clinic, Cleveland, OH,
U.S.A. |
New Agents and New Strategies
in Immunosuppression After Heart Transplantation
Bruno M. Meiser,
University of Munich, Klinikum Grosshadern, Munich, Germany |
Non-Transplant Surgery for
Heart Failure
Jai Raman,
The University of Chicago Medical Center, Chicago, Illinois,
U.S.A. |
First Results with Rapamycin
Replacing Cyclosporin After Heart Transplantation, Is There an
Advantage Concerning Graftsklerosis?
Suzanne Roedler,
University of Vienna, Vienna, Austria |
|